by Corina Milic | Nov 30, 2020
New formulation is dispersible and strawberry-flavored, enabling the youngest children living with HIV to be treated with the best available medication New price agreement with Viatris and Macleods will significantly lower cost for yearly pediatric HIV...
by Corina Milic | Nov 30, 2020
A long-awaited HIV treatment designed specifically for children will now be available in low-and middle-income countries, thanks to a landmark agreement from Unitaid and CHAI. The new pricing agreement with generic manufacturers Viatris and Macleods means a new...
by Corina Milic | Nov 27, 2020
This webinar, recorded Nov. 12, 2020, highlights key HIV market trends in low- and middle-income countries, based on CHAI’s annual market report, as well as a panel discussion focusing on what comes next as the global community grapples with both HIV and...
by Corina Milic | Nov 23, 2020
View CHAI’s 2019 990 form here. View CHAI’s 2018 990 form here. View CHAI’s 2017 990 form here. View CHAI’s 2016 990 form here. View CHAI’s 2015 990 form here. View CHAI’s 2014 990 form here. View CHAI’s 2013 990 form here. View CHAI’s 2012 990...
by Corina Milic | Nov 21, 2020
Antimicrobial resistance (AMR) is a global public health threat. Every year, a growing number of bacteria, viruses, fungi, and parasites become resistant to existing medications, making common infections harder to treat and increasing the risk of disease transmission,...
